This information is for healthcare professionals, however not intended for UK or Ireland audience.
Are you a healthcare professional (not UK or Ireland)?
Symptoms
Symptoms
Red flag symptoms
Red flag symptoms
Awareness of the full spectrum of systemic manifestations of hATTR is important for early recognition of suspicious signs and symptoms1
Read more
References
- Gertz M, Adams D et al., BMC Fam Pract. 2020 Sep 23;21(1):198.
- Conceição I et al. “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst. 2016;21(1):5–9.
- Gertz MA. Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges. Am J Manag Care. 2017;23(suppl 7):S107–S112.
- Donnelly JP & Hanna M. Cardiac amyloidosis: an update on diagnosis and treatment. Cleve Clin J Med. 2017;84(12 suppl 3):12–26.
- Adams D, Ando Y et al., J Neurol. 2021 Jun;268(6):2109-212.
- Monteiro C, Mesgazardeh JS et al. Predictive model of response to tafamidis in hereditary ATTR polyneuropathy. JCI Insight. 2019 Jun 20;4(12):e126526
- Amyloidosis Foundation. Understanding the patient voice in hereditary transthyretin-mediated amyloidosis (ATTR amyloidosis). Available at: https://www.amyloidosissupport.org/support_groups/fam_isabell_attr.pdf. Accessed April 2020.